Skip to main content

Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Training Course: Regulatory Affairs, Sales, Quality, and Analytical Departments (ONLINE EVENT: Apr 20th - Apr 21st, 2026) - ResearchAndMarkets.com

The "The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Training Course (Apr 20th - Apr 21st, 2026)" training has been added to ResearchAndMarkets.com's offering.

This course will benefit nitrosamine decision makers and those who can benefit from a broader understanding of the full picture of nitrosamines in regulatory affairs, sales, quality, and analytical departments.

Nitrosamine regulations are the most impactful change to our industry in recent years, affecting 30% of current and new products, including generics. Regulatory expectations have changed frequently and vary globally. In this webinar, we will discuss the major requirements and strategies. Those new to the subject and those growing their nitrosamine team will find value in seeing the entire picture. Experienced Small and Medium-sized Enterprises (SMEs) will receive detailed instructions for common pain points, like risk assessments.

Benefits of attending

  • Enhance your understanding of current regulatory framework and recent changes
  • See the full scope of work for your team members to understand how their part fits with the whole
  • Learn best practices for risk assessments
  • Inform next steps when your product is near or above regulatory limits through remediation, control strategies, and new research
  • Example products guide the way to practical understanding

Certification:

  • CPD: 6 hours for your records
  • Certificate of completion

Key Topics Covered:

Day 1

  • History and background
  • Classes of nitrosamines
  • Regulatory update
  • Team building
  • Risk assessments
  • At risk structures
  • Limit determination

Day 2

  • Nitrosation Assay Procedure (NAP) test
  • Analytical instruments and methods
  • Control strategy
  • Remediation
  • Post approval changes
  • Where are we going? Future state and unanswered questions

Speakers:

Jason Brown

Adare Pharma Solutions

Jason Brown brings a wealth of knowledge and practical experience to his role as Senior Analytical Sciences Manager at Adare Pharma Solutions, where he serves as the global nitrosamine subject matter expert. He has led Adare's innovative approaches to understanding nitrosamine formation, measurement, and mitigation to ensure regulatory compliance internally and for our customers. Jason has led numerous dialogues on the subject of nitrosamines through panel discussions, webinars, posters, articles, and regular contributions to the USP Nitrosamine Forum. Jason has a BS in Chemistry from George Fox University.

For more information about this training visit https://www.researchandmarkets.com/r/vv2bgh

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.10
+2.45 (1.04%)
AAPL  259.13
-0.83 (-0.32%)
AMD  237.66
+14.06 (6.29%)
BAC  52.75
+0.27 (0.51%)
GOOG  333.49
-2.82 (-0.84%)
META  622.20
+6.68 (1.08%)
MSFT  459.54
+0.16 (0.03%)
NVDA  188.72
+5.58 (3.05%)
ORCL  192.68
-0.93 (-0.48%)
TSLA  442.02
+2.82 (0.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.